No registrations found.
ID
Source
Health condition
Young males, Muscle protein synthesis
Sponsors and support
Intervention
Outcome measures
Primary outcome
Muscle protein synthesis rate (myofibrillar and mitochondrial)
Secondary outcome
• The fractional synthetic rate (FSR) of muscle protein synthesis (myofibrillar, and mitochondrial proteins) from 0-3 and 3-6 hours in the post-prandial period.
• Plasma free L-[ring-2H5]-phenylalanine enrichment (expressed as MPE)
• Plasma free L-[ring-2H4]-tyrosine enrichment (expressed as MPE)
• Plasma free L-[3,5-2H2]-tyrosine enrichment (expressed as MPE)
• Plasma free L-[ring-2H5]-phenylalanine enrichment
• Plasma free L-[1-13C]-leucine enrichment
• Plasma free L-[1-13C]-KIC enrichment
• Plasma total phenylalanine (expressed as ìmol/L)
• Plasma total tyrosine (expressed as ìmol/L)
• Total plasma amino acids (AAmax [ìmol/L])
• Plasma glucose (glucosemax [mmol/L])
• Plasma insulin (insulinmax [mU/L])
Background summary
Rationale: Dietary protein intake after exercise is necessary to maximally stimulate muscle protein synthesis rates [1]. Previous studies have shown that the ingestion of 20 grams of both egg and whey protein is sufficient to maximize both mixed and myofibrillar muscle protein synthesis after resistance type exercise [2, 3]. In addition, it has been observed that 20 grams of protein intake is sufficient to stimulate myofibrillar muscle protein synthesis, but not mitochondrial muscle protein synthesis, after endurance exercise [4]. It is reasonable to suggest that mitochondrial muscle protein synthesis may be particularly important for endurance athletes, as it will improve the oxidative capacity of the skeletal muscle in this athletic population. It remains to be elucidated whether higher doses (>20 grams) of protein ingestion are necessary to enhance mitochondrial muscle protein synthesis rates after endurance exercise. In addition, the effects of different doses of milk protein, as source of dietary protein, have never been tested on myofibrillar and mitochondrial muscle protein synthesis after endurance exercise. We aim to fill these gaps in our understanding.
Objective: To define the dose-response relationship after intrinsically labeled milk protein ingestion on whole-body, myofibrillar, and mitochondrial muscle protein synthesis after a single bout of endurance exercise in young men.
Study design: Parallel design, randomized, placebo controlled, double blind.
Study population: 48 young (20-30 y inclusive) healthy males.
Intervention (if applicable): Subjects will perform endurance exercise and consume a combination of carbohydrate (45 gr) and different doses of intrinsically labeled milk protein (0, 15, 30, 45 gr). In addition, continuous intravenous tracer infusions will be applied, with plasma and muscle samples collected.
Main study parameters/endpoints: Primary: myofibrillar, and mitochondrial protein bound [13C6] phenylalanine and [13C6] leucine enrichments. Secondary: plasma glucose, insulin, leucine, phenylalanine, tyrosine, plasma [13C6]phenylalanine, plasma [13C6] leucine, plasma D5-phenylalanine and plasma (3,5-D2)-tyrosine enrichments.
Study objective
30 grams of dietary protein ingestion is necessary to maximize whole-body, myofibrillar, and mitochondrial muscle protein synthetic response after a single bout of endurance exercise in healthy young males. Lower doses of protein (ie. 0 and 15 g) will be suboptimal while higher doses (ie. 45 g) will not induce a greater protein synthetic response.
Study design
t=0 drink; t=0 h, t=3 h, t=6 h skeletal muscle biopsies; 14 blood draws
Intervention
exercise bout and protein drink with different doses
T.A. Churchward-Venne
P.O. Box 616
Maastricht 6200 MD
The Netherlands
+31 43 388 2154
t.churchward-venne@maastrichtuniversity.nl
T.A. Churchward-Venne
P.O. Box 616
Maastricht 6200 MD
The Netherlands
+31 43 388 2154
t.churchward-venne@maastrichtuniversity.nl
Inclusion criteria
- Males
- Aged between 18-35 years
- Bodyweight between 65-95 kg inclusive
- Healthy, moderately trained
- BMI < 30 kg/m2
- Having given informed consent
Exclusion criteria
- Having any identified metabolic or intestinal disorders
- Use of tobacco products
- Non-steroidal anti-inflammatory drugs (NSAID) in the 4 days prior to the experimental trial
- Allergies to milk proteins (whey or casein)
- Arthritic conditions
- A history of neuromuscular problems
- Previous participation in amino acid tracer studies
- Individuals on any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescription strength acne medications).
- Diabetes
- Training more than 4 days per week
- VO2max < 35 ml/kg/min or > 70 ml/kg/min
- Phenylketonuria
- lactose intolerance
- blood donation within two months of study initiation
Design
Recruitment
IPD sharing statement
Plan description
Followed up by the following (possibly more current) registration
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
NTR-new | NL4973 |
NTR-old | NTR5111 |
CCMO | NL52519.068.15 |
OMON | NL-OMON42627 |